3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success Story - B&C-Gruppe

Institution: University of Natural Resources and Life Sciences, Vienna (BOKU), Department of Biotechnology Project lead: DI Miriam Klausberger, Ph.D., DI Mark Dürkop, Ph.D. Project description (German): Ein SARS-CoV-2-Antikörpertest gibt Auskunft darüber, ob jemand bereits mit dem Coronavirus infiziert war oder ob im Rahmen einer Impfung Antikörper gebildet wurden. Für den Antikörpernachweis nach einer Infektion oder […]

Abstracts 2022 North American Meeting for the Society of Medical Decision Making, October 23-26, 2022, 2023

Lepu Medical SARS-CoV-2 Antigen Rapid Test Kits, Colloidal Gold Test Kit Manufacturer/Supplier

Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools by means of agent-based simulations calibrated to cluster tracing data

3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success Story - B&C-Gruppe

Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria

bntx-20211231

HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual - 2022 - Journal of the International AIDS Society - Wiley Online Library

The territorial impact of COVID-19: Managing the crisis and recovery across levels of government

Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2: Molecular Therapy

On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination